Clinical Effectiveness of(VistaProof)in Comparison With ICDAS-II & Histological Validation for Detecting Occlusal Caries

Clinical Effectiveness of Quantitative Light Fluorescence Based Device (Vistacam Proof) in Comparison With ICDAS-II and Histological Validation in Detection of Initial Pits and Fissures Caries:: Diagnostic Accuracy Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03940170

Enrollment

Registered

2019-05-07

Start date

2020-05-01

Completion date

2021-08-09

Last updated

2021-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Light Fluorescence Device

Brief summary

a diagnostic accuracy study control trial is to be held to evaluate the Clinical performance of quantitative light fluorescence based device (Vistacam Proof) in comparison with the visual examination and histological validation in detection of initial pits and fissures caries

Interventions

DEVICEvistacam proof

Light fluorescence device

OTHERICDASII

visual examination

PROCEDUREfissurotomy

histological validation

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

15 Years to 50 Years

Inclusion criteria

* Patients aged from 15 to 50 years. * Patient at least has one posterior pits and fissure occlusal caries. * No gender restriction * Co-operative patients who signed the informed consent. * Good general health * Acceptable oral health

Exclusion criteria

* Pregnancy. * Disabilities. * Systemic disease or severe medical complications. * Allergic history concerning methacrylate. * Rampant caries.

Design outcomes

Primary

Measure	Time frame	Description
pits and fissure caries	through study completion, an average of 1 year	occlusal pits and fissure caries in posterior teeth non-cavitated

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026